{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:28:51Z","timestamp":1779895731195,"version":"3.53.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T00:00:00Z","timestamp":1245283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/bf03345743","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T05:48:05Z","timestamp":1395467285000},"page":"695-700","source":"Crossref","is-referenced-by-count":24,"title":["Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome"],"prefix":"10.1007","volume":"32","author":[{"given":"G.","family":"Targher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Solagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Castello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Spiazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zoppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Muggeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. P.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Moghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,18]]},"reference":[{"key":"BF03345743_CR1","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","volume":"84","author":"E Diamanti-Kandarakis","year":"1999","unstructured":"Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84: 4006\u201311.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR2","first-page":"2434","volume":"85","author":"M Asunci\u00f3n","year":"2000","unstructured":"Asunci\u00f3n M, Calvo RM, San Mill\u00e1n JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000, 85: 2434\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004, 89: 2745\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","volume":"41","author":"A Dunaif","year":"1992","unstructured":"Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992, 41: 1257\u201366.","journal-title":"Diabetes"},{"key":"BF03345743_CR5","first-page":"2694","volume":"83","author":"RS Legro","year":"1998","unstructured":"Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998, 83: 2694\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR6","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","volume":"83","author":"CM Ugarte De","year":"2005","unstructured":"DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005, 83: 1454\u201360.","journal-title":"Fertil Steril"},{"issue":"1","key":"BF03345743_CR7","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","volume":"48","author":"NM Alwis de","year":"2008","unstructured":"de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008, 48 (Suppl 1): S104\u201312.","journal-title":"J Hepatol"},{"issue":"1","key":"BF03345743_CR8","first-page":"S5","volume":"40","author":"JM Clark","year":"2006","unstructured":"Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006, 40 (Suppl 1): S5\u201310.","journal-title":"J Clin Gastroenterol"},{"key":"BF03345743_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","volume":"28","author":"A Kotronen","year":"2008","unstructured":"Kotronen A, Yki-J\u00e4rvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28: 27\u201338.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03345743_CR10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.fertnstert.2004.08.020","volume":"83","author":"JB Schwimmer","year":"2005","unstructured":"Schwimmer JB, Khorram O, Chiu V, Schwimmer WB. Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertil Steril 2005, 83: 494\u20137.","journal-title":"Fertil Steril"},{"key":"BF03345743_CR11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","volume":"91","author":"TL Setji","year":"2006","unstructured":"Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006, 91: 1741\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","volume":"47","author":"C Cerda","year":"2007","unstructured":"Cerda C, P\u00e9rez-Ayuso RM, Riquelme A, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 2007, 47: 412\u20137.","journal-title":"J Hepatol"},{"key":"BF03345743_CR13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","volume":"5","author":"M Gambarin-Gelwan","year":"2007","unstructured":"Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, Bodian C, Yeh HC, Futterweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007, 5: 496\u2013501.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BF03345743_CR14","first-page":"4426","volume":"85","author":"J Radziuk","year":"2000","unstructured":"Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000, 85: 4426\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR15","first-page":"139","volume":"85","author":"P Moghetti","year":"2000","unstructured":"Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000, 85: 139\u201346.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR16","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group.","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81: 19\u201325.","journal-title":"Fertil Steril"},{"key":"BF03345743_CR17","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006, 91: 4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","volume":"137","author":"D Prati","year":"2002","unstructured":"Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002, 137: 1\u201310.","journal-title":"Ann Intern Med"},{"key":"BF03345743_CR19","first-page":"952","volume":"81","author":"P Moghetti","year":"1996","unstructured":"Moghetti P, Tosi F, Castello R, et al. The insulin resistance in women with hyperandrogenism is partially reversed by anti-androgen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 1996, 81: 952\u201360.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR20","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1210\/jc.2007-0870","volume":"92","author":"R Pasquali","year":"2007","unstructured":"Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92: 4208\u201317.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR21","first-page":"881","volume":"81","author":"P Moghetti","year":"1996","unstructured":"Moghetti P, Castello R, Negri C, et al. Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adreno-corticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 1996, 81: 881\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345743_CR22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diacare.29.02.06.dc05-1478","volume":"29","author":"ME Zanolin","year":"2006","unstructured":"Zanolin ME, Tosi F, Zoppini G, et al. Clustering of cardiovascular risk factors associated with the insulin resistance syndrome: assessment by principal component analysis in young hyperandrogenic women. Diabetes Care 2006, 29: 372\u20138.","journal-title":"Diabetes Care"},{"key":"BF03345743_CR23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.01.075","volume":"134","author":"KM Korenblat","year":"2008","unstructured":"Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008, 134: 1369\u201375.","journal-title":"Gastroenterology"},{"key":"BF03345743_CR24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/dmrr.666","volume":"22","author":"RK Schindhelm","year":"2006","unstructured":"Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006, 22: 437\u201343.","journal-title":"Diabetes Metab Res Rev"},{"key":"BF03345743_CR25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","volume":"130","author":"CP Day","year":"2006","unstructured":"Day CP. From fat to inflammation. Gastroenterology 2006, 130: 207\u201310.","journal-title":"Gastroenterology"},{"key":"BF03345743_CR26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2008.64","volume":"16","author":"G Targher","year":"2008","unstructured":"Targher G, Bertolini L, Rodella S, et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) 2008, 16: 1394\u20139.","journal-title":"Obesity (Silver Spring)"},{"key":"BF03345743_CR27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","volume":"27","author":"MH Jarrar","year":"2008","unstructured":"Jarrar MH, Baranova A, Collantes R, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008, 27: 412\u201321.","journal-title":"Aliment Pharmacol Ther"},{"key":"BF03345743_CR28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","volume":"191","author":"G Targher","year":"2007","unstructured":"Targher G, Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, 191: 235\u201340.","journal-title":"Atherosclerosis"},{"key":"BF03345743_CR29","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44: 865\u201373.","journal-title":"Hepatology"},{"key":"BF03345743_CR30","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","volume":"54","author":"G Targher","year":"2005","unstructured":"Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005, 54: 3541\u20136.","journal-title":"Diabetes"},{"key":"BF03345743_CR31","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","volume":"30","author":"G Targher","year":"2007","unstructured":"Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007, 30: 2119\u201321.","journal-title":"Diabetes Care"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345743.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345743\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:25:57Z","timestamp":1558506357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,18]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BF03345743"],"URL":"https:\/\/doi.org\/10.1007\/bf03345743","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,18]]}}}